Key facts
- This page summarizes Mahkam Zanganeh's Form 4 filing for Summit Therapeutics Inc. (SMMT).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 01 May 2025, 18:03.
Mahkam Zanganeh - 29 Apr 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)
- Reporting relationship
- Co-Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- SMMT
- Reported as of
- 29 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 May 2025, 18:03:44 UTC
- Prior SEC filing
- 09 Apr 2025
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mahkam Zanganeh
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mahkam Zanganeh filed Form 4 for Summit Therapeutics Inc. (SMMT) on 01 May 2025.
Change
- Previous filing in this sequence was filed on 09 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SMMT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +1,040,000
- Change %
- Price
- Shares after
- 1,040,000
- Date
- 29 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,040,000
- Exercise price
- $1.06
- Footnotes
- F1, F2
SMMT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +400,000
- Change %
- Price
- Shares after
- 400,000
- Date
- 29 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 400,000
- Exercise price
- $1.29
- Footnotes
- F1, F2
SMMT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +9,590,558
- Change %
- Price
- Shares after
- 9,590,558
- Date
- 29 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,590,558
- Exercise price
- $1.68
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025.
Footnote F2
Not applicable.